FARA Job Posting: Associate Director of Research

Click to view PDF
FARA is seeking a full time Associate Director of Research.
Please click HERE for more information.

2022 (62)
- May (6)
  - • ICAR - Abstract Deadline Appr…
  - • Reata Pharmaceuticals has ann…
  - • Frataxin deficiency lowers le…
  - • 2022 HRS expert consensus sta…
  - • Increased brain tissue sodium…
  - • Inherited Ataxias in Children
- April (11)
  - • Posttranslational Regulation …
  - • Cognitive Dysfunction in Repe…
  - • Towards a metabolomic approac…
  - • The smoothened agonist SAG re…
  - • Yeast cells depleted of the f…
  - • Predicting Mitochondrial Dyna…
  - • Cerebellar Pathology in an In…
  - • Informational Webinar on CDRM…
  - • Bone Mineral Density and Curr…
  - • Aberrant Cerebral Iron Traffi…
  - • Functional MRI Studies in Fri…
- March (28)
  - • Reata Pharmaceuticals Complet…
  - • Design Therapeutics Completes…
  - • DNA methylation in Friedreich…
  - • Modelling Protein Plasticity:…
  - • Recessive cerebellar and affe…
  - • Should Advanced Friedreich's …
  - • Stealth BioTherapeutics Recei…
  - • Recent Advances in the Elucid…
  - • Friedreich's Ataxia Related D…
  - • Difficulties translating anti…
  - • The cognitive profile of Frie…
  - • Quantitative susceptibility m…
  - • Control of arm movements in F…
  - • New Funding Opportunities for…
  - • Selected Histone Deacetylase …
  - • Gene therapy for Friedreich a…
  - • Heat and cold denaturation of…
  - • Cur@SF NPs alleviate Friedrei…
  - • Serum glial fibrillary acidic…
  - • In vivo overexpression of fra…
  - • Heme oxygenase-nitric oxide c…
  - • Downregulation of Three Immun…
  - • ICAR 2022: Keynote Address
  - • Reata Pharmaceuticals Fourth …
  - • Design Therapeutics Announces…
  - • Drug Repositioning in Friedre…
  - • Protein Mutations and Stabili…
  - • MRI CNS Atrophy Pattern and t…
- February (8)
  - • Meet the team at University o…
  - • A Standardized Pipeline for E…
  - • Whole genome sequencing for t…
  - • Mitochondrial Dynamics and Mi…
  - • SARS-CoV-2 attacks the weakes…
  - • FARA Flash Talk Series 2022 -…
  - • LEXEO Announces FDA Clearance…
  - • Retrotope announces Phase 2/3…
- January (9)
  - • Reata Pharmaceuticals Initiat…
  - • FARA Grants - 2022 Upcoming D…
  - • Therapeutic Strategies Target…
  - • Mice harboring the FXN I151F …
  - • During FeS-cluster biogenesis…
  - • Hsa-miR223-3p circulating lev…
  - • Current Drug Repurposing Stra…
  - • Transcriptional Analysis of N…
  - • The attitude of patients with…
2021 (128)
- December (13)
  - • Friedreich's Ataxia Frequency…
  - • Nuclear Factor Erythroid-2-Re…
  - • A Combined Spectroscopic and …
  - • Longitudinal Assessment Using…
  - • Epigenetic Heterogeneity in F…
  - • The Dynamin-Related Protein 1…
  - • Characterizing cardiac phenot…
  - • A pathogenic role for histone…
  - • Exicure, Inc. Announces Resul…
  - • The Responsiveness of Gait an…
  - • Rad9-mediated checkpoint acti…
  - • Pharmacotherapy of cerebellar…
  - • ICAR 2022 HAS BEEN POSTPONED
- November (18)
  - • Source of medical information…
  - • Myocardial and Arrhythmic Spe…
  - • Molecular characteristics of …
  - • Conformational stability, dyn…
  - • Cellular pathophysiology of F…
  - • Body Mass Index and Height in…
  - • Body Mass Index and Height in…
  - • FARA announces new Grant Prog…
  - • Reata Pharmaceuticals Receive…
  - • Diagnosis and Management of C…
  - • Molecular approaches for the …
  - • Mitochondrial iron metabolism…
  - • Clinical and Molecular Featur…
  - • Left atrial appendage thrombo…
  - • History of Ataxias and Parapl…
  - • Objective Assessment of Progr…
  - • Targeting 3' and 5' untransla…
  - • Tract-Specific Spinal Cord Di…
- October (10)
  - • Designing phase II clinical t…
  - • Construction of DNA/RNA Tripl…
  - • Mitochondrial Iron-Sulfur Clu…
  - • Longitudinal investigation of…
  - • Request For Proposals: Pharma…
  - • In vivo assessment of OXPHOS …
  - • Neuroinflammation in the Cere…
  - • Friedreich's ataxia-associate…
  - • NeuroVoices: David R. Lynch, …
  - • Adaptation of the heart to Fr…
- September (7)
  - • Reata Pharmaceuticals Plans N…
  - • Age of onset modulates restin…
  - • Blood Neurofilament Light Cha…
  - • Plasma idebenone monitoring i…
  - • A mitochondrial membrane-brid…
  - • LEXEO Therapeutics Closes $10…
  - • Three Adult-Onset Autosomal R…
- August (12)
  - • Neuro-Ophthalmological Findin…
  - • Brain Structure and Degenerat…
  - • Mechanisms of impaired mitoch…
  - • Treatment with ROS detoxifyin…
  - • SS-31 efficacy in a mouse mod…
  - • Reata Pharmaceuticals, Inc. A…
  - • Design Therapeutics Reports G…
  - • Copper, Iron, and Manganese T…
  - • The Role of Voltage-Dependent…
  - • Digital endpoints for self-ad…
  - • Diagnostic and Prognostic Val…
  - • Polyuria and Acute Hyperglyce…
- July (9)
  - • Very late-onset Friedreich's …
  - • Interruptions of the FXN GAA …
  - • Rare occurrence of severe bli…
  - • Friedreich Ataxia: Multidisci…
  - • Myocardial Perfusion Reserve …
  - • Differential efficacies of Ca…
  - • The Cost of Living with Inher…
  - • Generation of transgene-free …
  - • Molecular Details of the Frat…
- June (10)
  - • LEXEO Therapeutics Receives R…
  - • A Focus on "Bio" in Bio-Nanos…
  - • The cardiomyopathy of Friedre…
  - • CRISPR Therapeutics and Capsi…
  - • Friedreich ataxia in a family…
  - • Frataxin and endothelial cell…
  - • Iron-sulfur cluster deficienc…
  - • Mitochondrial and metabolic d…
  - • An unusual combination of lar…
  - • Generation of a Friedreich's …
- May (13)
  - • The Oxford-Harrington Rare Di…
  - • Larimar Therapeutics Reports …
  - • Results of a randomized doubl…
  - • Larimar Therapeutics Receives…
  - • Reata Announces that The FDA …
  - • Reverse phase protein array r…
  - • Larimar Therapeutics Reports …
  - • Drp1-dependent peptide revers…
  - • Scoliosis in Friedreich's ata…
  - • April Monthly Update for Rese…
  - • Frataxin deficiency promotes …
  - • The Cardioprotective Mechanis…
  - • Variable-Temperature Electros…
- April (3)
- March (14)
  - • Quantitative assessment of Fr…
  - • Somatic CAG expansion in Hunt…
  - • Progression characteristics o…
  - • Pre-clinical left ventricular…
  - • March Monthly Update for Rese…
  - • The Role of Serum Levels of N…
  - • In vivo survival and differen…
  - • Synthesis of 5-[(1H-indol-3-y…
  - • Nuclear Factor Erythroid 2-Re…
  - • Systematic Review: Quantitati…
  - • Ectopic Burden via Holter Mon…
  - • Crosstalk between nucleus and…
  - • Frataxins Emerge as New Playe…
  - • Future Prospects of Gene Ther…
- February (9)
  - • Safety and feasibility of upp…
  - • The displacement of frataxin …
  - • The Complex Genetic Landscape…
  - • Retrotope Granted Rare Pediat…
  - • Auditory Phenotypic Variabili…
  - • Prognostic value of longitudi…
  - • Modifiers of Somatic Repeat I…
  - • Gauging Gait Disorders with a…
  - • Defective palmitoylation of t…
- January (10)
  - • DNA repair pathways are alter…
  - • Replication-independent insta…
  - • Efficacy of echocardiography …
  - • Dimethyl fumarate dose-depend…
  - • Methylated and unmethylated e…
  - • Omaveloxolone: potential new …
  - • Hand Dexterity and Pyramidal …
  - • Friedreich ataxia in COVID-19…
  - • LEXEO Therapeutics Launches w…
  - • Developing an Instrumented Me…
2020 (134)
- December (10)
  - • Cardiomyopathy as the first m…
  - • Effects of Fe 2+/Fe 3+ Bindin…
  - • Efficacy and Tolerability of …
  - • Exicure Provides Neuroscience…
  - • Thioredoxin and Glutaredoxin …
  - • Minoryx's clinical candidate …
  - • Calcitriol increases frataxin…
  - • Larimar Therapeutics Announce…
  - • Mitochondrial dysfunction in …
  - • Molecular Defects in Friedrei…
- November (13)
  - • Central Nervous System Therap…
  - • High Levels of Frataxin Overe…
  - • The Nrf2 induction prevents f…
  - • Antiferroptotic Activity of P…
  - • Ferroptosis in Friedreich's A…
  - • Analysis of Postural Control …
  - • PPAR gamma agonist leriglitaz…
  - • Sensitivity of Neuroimaging I…
  - • Effect of Mitochondrial and C…
  - • Electrocardiogram in Friedrei…
  - • Epicardial ablation for ventr…
  - • An Overview of the Ferroptosi…
  - • Oxidative stress modulates re…
- October (14)
  - • Aerobic Exercises Induce Anti…
  - • Safety and Efficacy of Omavel…
  - • Clinical Therapeutic Manageme…
  - • Longitudinal Study of Cogniti…
  - • Sexual function, intimate rel…
  - • Assessment of Disease Progres…
  - • Clinical Features and Molecul…
  - • Inhibition of the SUV4-20 H1 …
  - • Assessment of Ataxia Rating S…
  - • Quantitative Assessment of Fr…
  - • Oxidative stress-dependent fr…
  - • Mechanistic concepts of iron-…
  - • Expanding the genotype-phenot…
  - • Loss of mitochondrial localiz…
- September (12)
  - • Extra-mitochondrial mouse fra…
  - • A Highly Conserved Iron-Sulfu…
  - • Global, multi-stakeholder, co…
  - • Emerging therapies in Friedre…
  - • Iron-sulfur cluster protein N…
  - • Altered Secretome and ROS Pro…
  - • Iron-Sulfur Cluster Complex A…
  - • Molecular and Cellular Substr…
  - • HDAC3 deacetylates the DNA mi…
  - • Plasma and red blood cell mem…
  - • The Friedreich’s Ataxia Acc…
  - • Ataxia: Hope starts with meas…
- August (14)
  - • Friedreich Ataxia: current st…
  - • Frataxin gene editing rescues…
  - • Inherited Cerebellar Ataxias:…
  - • Atypical structures of GAA/TT…
  - • Reata provides update on deve…
  - • Test-retest reliability of th…
  - • Distribution of Particles in …
  - • Identification of a Novel Ole…
  - • R-loops promote trinucleotide…
  - • Onset features and time to di…
  - • A Drosophila model of Friedre…
  - • Antioxidant Defense Mechanism…
  - • Toward quantitative neuroimag…
  - • Antioxidant Therapies and Oxi…
- July (11)
  - • Larimar Therapeutics Announce…
  - • Relationship between activity…
  - • Current Status of microRNA-Ba…
  - • Safety and Efficacy of (+)-Ep…
  - • MR imaging and spectroscopy i…
  - • Cardiolipin-deficient cells h…
  - • Compound heterozygosity for a…
  - • Trinucleotide Repeat Disorder…
  - • Stress-induced Mouse Model of…
  - • A Novel Solution-Gated Graphe…
  - • New Request For Proposals: Th…
- June (10)
  - • Mitochondrial Damage and Sene…
  - • HMTase Inhibitors as a Potent…
  - • Feasibility and Acceptability…
  - • Treatment of Dilated Cardiomy…
  - • Defining Transcription Regula…
  - • Vestibular Impact of Friedrei…
  - • Cerebellar Cognitive Disorder…
  - • Significance of NT-proBNP and…
  - • CRISPR-Cas9 Gene Editing of H…
  - • Hereditary Ataxia: A Focus on…
- May (9)
  - • Chondrial Therapeutics and Za…
  - • Analysis of Putative Epigenet…
  - • Making iron-sulfur cluster: s…
  - • Neurofilament Light Chain as …
  - • Primary Proprioceptive Neuron…
  - • Oxidative Stress in DNA Repea…
  - • Neurologic Outcomes in Friedr…
  - • Therapeutic Potential of Stem…
  - • ExpansionHunter Denovo: A Com…
- April (10)
  - • Oxidative Stress, a Crossroad…
  - • Outlining the Complex Pathway…
  - • Progress Towards Drug Discove…
  - • A Comprehensive Transcriptome…
  - • An Overview of the Current St…
  - • Long-term voluntary running p…
  - • Calpain-Inhibitors Protect Fr…
  - • Cofilin dysregulation alters …
  - • Particle-mediated delivery of…
  - • Frataxin-deficient cardiomyoc…
- March (7)
  - • A wearable video-oculography …
  - • Neurophysiologic intraoperati…
  - • Design Therapeutics Launches …
  - • Identification of Frataxin as…
  - • The Assessment of Upper Limb …
  - • Inherited Metabolic Diseases …
  - • Management of Neuroinflammato…
- February (8)
  - • Psychometric properties of th…
  - • On the wrong DNA track: Molec…
  - • The Potential of the Novel NA…
  - • Ocular Involvement in Friedre…
  - • The NRF2 Signaling Network De…
  - • Mechanisms of Mitochondrial I…
  - • Developing an objective evalu…
  - • NfL and pNfH are increased in…
- January (16)
  - • Correlation of Visual Quality…
  - • Frataxin deficiency induces l…
  - • Imaging neuronal activity in …
  - • An Instrumented Measurement S…
  - • Predictors of loss of ambulat…
  - • Frataxin Structure and Functi…
  - • Safety and Efficacy of Interf…
  - • Frataxin deficiency in Friedr…
  - • Health related quality of lif…
  - • Multiple mechanisms underpin …
  - • Large-scale contractions of F…
  - • MDA Awards Venture Philanthro…
  - • Mammalian iron-sulfur cluster…
  - • Retrotope Expands its Drug Pi…
  - • Longitudinal Increases in Cer…
  - • Genetic Analysis of Hereditar…
2019 (102)
- December (16)
  - • Exenatide induces frataxin ex…
  - • Nanoscopic X-ray imaging and …
  - • Age of onset determines intri…
  - • A new tool to determine the c…
  - • Electrophysiological evidence…
  - • Neurochemical profiles in her…
  - • Iron Hack - A symposium/hacka…
  - • Chondrial Therapeutics Announ…
  - • Zafgen and Chondrial Therapeu…
  - • Exicure Announces First Neuro…
  - • Effects of tocotrienol supple…
  - • Friedreich's Ataxia: Case ser…
  - • Mitochondrial dysfunction in …
  - • Pediatric Neuromuscular Disor…
  - • N-Terminomics/TAILS Profiling…
  - • Possible Mechanisms of Biolog…
- November (11)
  - • Left ventricular structural a…
  - • Global Ataxia Advocacy Organi…
  - • Orphan Drugs In Development F…
  - • Temporal but not spatial dysm…
  - • Quantitative Proteomic and Ne…
  - • Refinement of protein Fe(II) …
  - • Evolutionarily conserved susc…
  - • Speech and Language Disorders…
  - • The Structure of the Human AC…
  - • Potential biomarker identific…
  - • The first biallelic missense …
- October (11)
  - • Targeting NRF2 for the Treatm…
  - • Cerebellum and cognition in F…
  - • Predictors of Left Ventricula…
  - • Induced pluripotent stem cell…
  - • Minoryx Therapeutics receives…
  - • Reata Announces Positive Topl…
  - • Primary Cultures of Pure Embr…
  - • Changes detected in swallowin…
  - • SINEUP non-coding RNAs rescue…
  - • Minoryx Therapeutics complete…
  - • Health-related quality of lif…
- September (6)
  - • Unique roles of iron and zinc…
  - • Mechanism of activation of th…
  - • Two new Pfizer-coauthored stu…
  - • Scoliosis in Patients With Fr…
  - • Friedreich ataxia- pathogenes…
  - • The Working Life of People wi…
- August (7)
  - • Backbone resonance assignment…
  - • Application of Quantitative M…
  - • Oral mobility reflects rate o…
  - • Excision of the expanded GAA …
  - • Folding and Dynamics are Stro…
  - • Nrf2 Induction Re-establishes…
  - • Physiologically relevant reco…
- July (8)
  - • Exploring iron-binding to hum…
  - • Low frataxin mRNA expression …
  - • REGENXBIO Announces New Licen…
  - • Molecular Mechanisms and Ther…
  - • New developments in pharmacot…
  - • The current state of biomarke…
  - • Correlation between frataxin …
  - • Evaluation of antibodies for …
- June (11)
  - • Frequency and Genetic Profile…
  - • FARA Job Posting: Associate D…
  - • Evidence for genetically dete…
  - • Open label Pilot Study of Ora…
  - • Deuterated Polyunsaturated Fa…
  - • Altered neocortical tactile b…
  - • Young Investigators: Call for…
  - • Microvascular pathology in Fr…
  - • p53 Binds Preferentially to N…
  - • Dimethyl fumarate dosing in h…
  - • Efficient Electroporation of …
- May (5)
- April (5)
- March (7)
  - • StrideBio and Takeda Sign Col…
  - • Patient reported outcomes in …
  - • Assessment of cell-free level…
  - • Inherited Ataxia and Intrathe…
  - • The role of robotic gait trai…
  - • The Role of Iron in Friedreic…
  - • Progress in understanding Fri…
- February (8)
  - • C-Path and FARA announce the …
  - • Minoryx Therapeutics receives…
  - • Guidelines on the diagnosis a…
  - • In Vitro interaction between …
  - • The role of mitochondrial lab…
  - • Pattern of Cerebellar Atrophy…
  - • Phosphodiesterase Inhibitors …
  - • Heart disease in Friedreich's…
- January (7)
  - • Neurocrine Biosciences and Vo…
  - • OGTT is recommended for gluco…
  - • Ferroptosis as a novel therap…
  - • Structural and functional cha…
  - • Longitudinal evaluation of ir…
  - • Drug repositioning screening …
  - • Differences in the determinan…
2018 (68)
- December (5)
- November (7)
  - • FAST-1 antisense RNA epigenet…
  - • Characterization of a new N-t…
  - • Rapid and Complete Reversal o…
  - • Oligonucleotides Hold Promise…
  - • Voyager Therapeutics Announce…
  - • Safety, pharmacodynamics, and…
  - • Plasma Markers of Neurodegene…
- October (6)
  - • Intraepidermal Nerve Fiber De…
  - • Calcium Deregulation: Novel I…
  - • Developmental and Neurodegene…
  - • Corneal Confocal Microscopy: …
  - • Phenothiazine antioxidants in…
  - • Automated functional upper li…
- September (5)
- August (6)
  - • Test-retest reliability of an…
  - • Two funded post-doctoral posi…
  - • Nonataxia symptoms in Friedre…
  - • Activating frataxin expressio…
  - • Novel Nrf2-Inducer Prevents M…
  - • Longitudinal analysis of cont…
- July (7)
  - • RNA-Dependent Epigenetic Sile…
  - • Zinc(II) binding on human wil…
  - • PTC Therapeutics to acquire A…
  - • Young Investigators, Call for…
  - • Impact of Drosophila Models i…
  - • Autonomic function testing in…
  - • Structural characteristics of…
- June (5)
- May (5)
- April (3)
- March (9)
  - • Identification of p38 MAPK as…
  - • Iron regulatory protein defic…
  - • Mitofusin-Dependent ER Stress…
  - • GAA•TTC repeat expansion in…
  - • Pitfalls in molecular diagnos…
  - • Bone marrow transplantation s…
  - • Biophysical characterisation …
  - • Small RNA-seq analysis of cir…
  - • Progress in the treatment of …
- February (3)
- January (7)
  - • Activation of Frataxin Protei…
  - • Join Reata WebEx. Get updates…
  - • Quantitative proteomics in Fr…
  - • The role of Nrf2 signaling in…
  - • Effect Of Diazoxide on Friedr…
  - • Emotion Recognition and Psych…
  - • Friedreich and dominant ataxi…
2017 (6)
- December (6)
  - • Liquid Chromatography-High Re…
  - • Early VGLUT1-specific paralle…
  - • Somatic instability of the ex…
  - • Inducible and reversible phen…
  - • Mitochondrial pore opening an…
  - • The role of oxidative stress …

FARA Job Posting: Associate Director of Research

SHARE

Archived in
Scientific News

Tagged in
FARA Scientific News

Funded Research

Supported Research

SHARE

Archived in Scientific News

Tagged in FARA Scientific News

Funded Research

Supported Research

Archived in
Scientific News

Tagged in
FARA Scientific News